← Back to Clinical Trials
Recruiting NCT03371407

NCT03371407 Movement Error-processes and Sensorimotor Adaptation in Parkinsonian Patient

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT03371407
Status Recruiting
Phase
Sponsor Assistance Publique Hopitaux De Marseille
Condition Parkinson Disease
Study Type OBSERVATIONAL
Enrollment 100 participants
Start Date 2019-07-04
Primary Completion 2027-10

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Assessment of behavioral performance and the electrophysiological (EEG) activity in PD patients during the early and more advanced stages of the pathology

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 100 participants in total. It began in 2019-07-04 with a primary completion date of 2027-10.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of the present project is to document the relationship between the behavioral deficits and the electrophysiological anomalies observed in PD patients in tasks involving motor adaptation to visual or mechanical perturbations.

Eligibility Criteria

Inclusion Criteria: * Patient aged over 18 years * Right-handed patients , following the Modified Edinburgh Handedness Inventory * Patient with Parkinson's disease according to Gibb criteria * Idiopathic Parkinson's Disease with a history of more than 5 years * Stimulation electrodes implanted in the 2 subthalamic nuclei in the Functional and Stereotactic Neurosurgery Department of La Timone Hospital (Pr REGIS). * Dopa-sensitivity greater than 50% * Absence of signs of cognitive impairment * Patient who agreed to participate in the study and signed informed consent * Patient affiliated with a health insurance Exclusion Criteria: * Person not likely to participate in the entire study * Pregnant or likely to be pregnant during the year * Patients unable to give their informed consent (detainees, adults under guardianship) * Person unable to understand the nature and purpose of the study, or presneting with understanding difficulties which could compromise the proper conduct of the study * Person refusing to sign the Informed Consent Form * A person who is able to give his or her consent but unable to read / write French language * patient who can not participate in an MRI study according to the criteria listed in the attached form.

Contact & Investigator

Central Contact

Alexandre EUSEBIO, MD, PHD

✉ alexandre.eusebio@ap-hm.fr

📞 +33491384333

Principal Investigator

Urielle DESALBRES

STUDY DIRECTOR

Assistance Publique Hôpitaux de Marseille

Frequently Asked Questions

Who can join the NCT03371407 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Parkinson Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT03371407 currently recruiting?

Yes, NCT03371407 is actively recruiting participants. Contact the research team at alexandre.eusebio@ap-hm.fr for enrollment information.

Where is the NCT03371407 trial being conducted?

This trial is being conducted at Marseille, France.

Who is sponsoring the NCT03371407 clinical trial?

NCT03371407 is sponsored by Assistance Publique Hopitaux De Marseille. The principal investigator is Urielle DESALBRES at Assistance Publique Hôpitaux de Marseille. The trial plans to enroll 100 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology